Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motherhood choice in multiple sclerosis (MoMS) - Pilot trial of web-based decision support.

PloS one·2026
Same author

Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders.

Neurological research and practice·2026
Same author

Early use of high-efficacy disease-modifying therapies reduces the risk of progression independent of relapse and MRI activity in patients with relapsing-remitting multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Reassessing dissemination in space: The role of spinal cord lesion burden in early multiple sclerosis diagnosis.

Multiple sclerosis and related disorders·2026
Same author

Family Planning in Neuroinflammatory Disease.

Continuum (Minneapolis, Minn.)·2026
Same journal

A novel JAK1 mutation identified in a patient with severe atopic dermatitis phenotype: Mechanistic insights and IL-4Rα targeted therapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

VNN1 aggravates sepsis by promoting inflammation and oxidative stress through PPARγ signaling VNN1 in sepsis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Comparison between glioblastoma and brain metastases: How epigenetic remodeling can enhance immunotherapy.

Clinical immunology (Orlando, Fla.)·2026
Same journal

JAK-STAT3-MYC axis defines pathogenic stem cell-like memory CD4<sup>+</sup> T cells in rheumatoid arthritis.

Clinical immunology (Orlando, Fla.)·2026
Same journal

The baseline vaginal immune milieu is an important determinant of the inflammatory response induced by penile-vaginal sex.

Clinical immunology (Orlando, Fla.)·2026
Same journal

Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.

Clinical immunology (Orlando, Fla.)·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Artificial reproductive techniques in multiple sclerosis.

Kerstin Hellwig1, Jorge Correale

  • 1Department of Neurology, St. Josef Hospital Bochum, Ruhr University Bochum, Germany.

Clinical Immunology (Orlando, Fla.)
|March 20, 2013
PubMed
Summary
This summary is machine-generated.

Women with multiple sclerosis (MS) may experience increased relapse rates after assisted reproductive treatment (ART). Neurologists should discuss the risks of ART, including potential MS worsening, with patients.

Keywords:
Assisted reproductive treatmentAutoimmunityHormonesIn vitro fertilizationMultiple sclerosis

More Related Videos

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination
05:36

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination

Published on: July 7, 2023

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: May 13, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination
05:36

Inducing Pseudopregnancy in Female Mice Without the Need for Vasectomized Males Prior to Non-Surgical Embryo Transfer or Artificial Insemination

Published on: July 7, 2023

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Neurology
  • Immunology
  • Reproductive Medicine

Background:

  • Fertility is not significantly impaired in women with multiple sclerosis (MS).
  • MS patients may undergo assisted reproductive treatment (ART) due to coincidental infertility.
  • Previous studies indicate a potential link between ART and MS relapses.

Purpose of the Study:

  • To evaluate the effects of ART on MS relapses.
  • To investigate the association between ART and clinical worsening in MS.
  • To identify potential mechanisms driving MS exacerbation post-ART.

Main Methods:

  • Review of studies examining ART outcomes in women with MS.
  • Analysis of annualized relapse rates following ART.
  • Correlation of MRI activity with clinical worsening post-ART.

Main Results:

  • Multiple studies report an increased annualized relapse rate after ART in MS patients.
  • Clinical worsening in MS has been associated with increased MRI activity post-ART.
  • Potential mechanisms include therapy interruption, stress, hormonal immune changes, and increased immune cell migration.

Conclusions:

  • ART may increase the risk of MS relapses and clinical worsening.
  • Neurologists must counsel MS patients on the risks and benefits of ART.
  • Awareness of ART's potential impact on MS is crucial for patient management.